Veracyte (VCYT) Stock Price & Analysis

VCYT$24.33-0.30 -1.22%
Medical - Diagnostics & ResearchGrowth StockHigh Quality
Compare
Market cap$1.96BEnterprise value$1.77BRevenue (TTM)$581.78MMarket position—

Score

65
Bullish
Value
44
Quality
79
Growth
71

AI Analysis

Snapshot

Veracyte mixes growth with a still-reasonable multiple — Growth 71/100 with P/E 15.1. Under the hood: P/E 15.1, plus revenue compounding ~20% annually over recent years. Street targets still imply ~123% upside.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

44
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

71
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

79
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

Veracyte, Inc. (VCYT) last printed $24.33. Equity value is $1.96B. Trailing earnings multiple 15.44. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2016201720182019202020212022202320242025
$65.08M$71.95M$92.01M$120.37M$117.48M$219.51M$296.54M$361.05M$445.76M$517.14M

About

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

Veracyte (VCYT) Stock Price & Analysis

VCYT price $24.33 -0.30 -1.22%

Ticker
VCYT
Price
$24.33
Change
-0.30 -1.22%
Market cap
$1.96B
P/E
15.44
Forward P/E
27.28
Dividend yield
0.00%
Beta
1.96
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Stocklytics score
65
Value
44
Quality
79
Growth
71

Stocklytics score rationale: value 44, quality 79, growth 71.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener